Effects of Intranasal Insulin Administration on Cerebral Blood Flow and Cognitive Performance in Adults: A Systematic Review of Randomized, Placebo-Controlled Intervention Studies

Introduction: Brain insulin resistance is an important hallmark of age-related conditions, including type 2 diabetes (T2D) and dementia. This systematic review summarized effects of cerebral blood flow (CBF) responses to intranasal insulin to assess brain insulin sensitivity in healthy and diseased populations. We also explored relationships between changes in brain insulin sensitivity and cognitive performance. Methods: A systemic literature search (PROSPERO: CRD42022309770) identified 58 randomized, placebo-controlled trials (RCTs) that investigated effects of intranasal insulin on (regional) CBF, cognitive performance, and systemic spill-over in adults. Results: Acute intranasal insulin did not affect whole-brain CBF in healthy adults, but increased regional CBF of the inferior frontal gyrus, dorsal striatum, and insular cortex, and reduced CBF around the middle frontal gyrus and hypothalamus. Obese adults showed increased CBF responses following internasal insulin for the middle frontal gyrus but decreased CBF for hypothalamic and cortico-limbic regions. Furthermore, increased CBF responses were reported for the insular cortex in T2D patients and for occipital and thalamic regions in older adults. The spray also improved memory and executive function, but a causal relation with regional CBF still needs to be established. Finally, intranasal insulin resulted in only a small amount of systemic spill-over, which is unlikely to have an impact on the observed findings. Conclusions: Region-specific changes in CBF after intranasal insulin administration were affected by obesity, T2D, and normal aging, indicating altered brain insulin sensitivity. Future RCTs should investigate longer-term effects of intranasal insulin and explore potential associations between effects on CBF and cognitive performance.

[1]  A. Krishnamurthy,et al.  Hippocampus and its involvement in Alzheimer’s disease: a review , 2022, 3 Biotech.

[2]  Xiaoyan Lei,et al.  Altered Functional Connectivity of Insular Subregions in Type 2 Diabetes Mellitus , 2021, Frontiers in Neuroscience.

[3]  J. Kramer,et al.  APOE moderates the effect of hippocampal blood flow on memory pattern separation in clinically normal older adults , 2021, Hippocampus.

[4]  M. Hallschmid.  Intranasal Insulin for Alzheimer’s Disease , 2021, CNS Drugs.

[5]  A. Newberg,et al.  Patterns of Regional Cerebral Blood Flow as a Function of Obesity in Adults , 2020, Journal of Alzheimer's disease : JAD.

[6]  R. Rodriguez-Raecke,et al.  Virtual grocery shopping and cookie consumption following intranasal insulin or placebo application. , 2020, Experimental and clinical psychopharmacology.

[7]  S. Craft,et al.  Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches , 2020, The Lancet Neurology.

[8]  Chenghua Gu,et al.  Neuronal regulation of the blood–brain barrier and neurovascular coupling , 2020, Nature Reviews Neuroscience.

[9]  O. O'Daly,et al.  Intranasal insulin administration decreases cerebral blood flow in cortico‐limbic regions: A neuropharmacological imaging study in normal and overweight males , 2020, Diabetes, obesity & metabolism.

[10]  H. Preissl,et al.  Brain insulin sensitivity is linked to adiposity and body fat distribution , 2020, Nature Communications.

[11]  W. Frey,et al.  Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome , 2020, Drugs in R&D.

[12]  T. Michael,et al.  Effects of intranasal insulin as an enhancer of fear extinction: a randomized, double-blind, placebo-controlled experimental study , 2020, Neuropsychopharmacology.

[13]  Chelsea C. Hays,et al.  APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults , 2019, NeuroImage.

[14]  Natalie S Blencowe,et al.  RoB 2: a revised tool for assessing risk of bias in randomised trials , 2019, BMJ.

[15]  M. Tittgemeyer,et al.  Modulation of midbrain neurocircuitry by intranasal insulin , 2019, NeuroImage.

[16]  F. Zelaya,et al.  Characterisation of nasal devices for delivery of insulin to the brain and evaluation in humans using functional magnetic resonance imaging. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[17]  P. Novak,et al.  Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study , 2019, PloS one.

[18]  M. Hallschmid,et al.  Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men , 2018, Front. Endocrinol..

[19]  P. Dandona,et al.  Intranasal Insulin Administration Does Not Affect LH Concentrations in Men with Diabetes , 2018, International journal of endocrinology.

[20]  J. Freiherr,et al.  Odor Sensitivity After Intranasal Insulin Application Is Modulated by Gender , 2018, Front. Endocrinol..

[21]  H. Lipp,et al.  Safety of intranasal human insulin: A review , 2018, Diabetes, obesity & metabolism.

[22]  Xavier Golay,et al.  Overview and Critical Appraisal of Arterial Spin Labelling Technique in Brain Perfusion Imaging , 2018, Contrast media & molecular imaging.

[23]  Thomas T. Liu,et al.  Cerebral Blood Flow Measurements in Adults: A Review on the Effects of Dietary Factors and Exercise , 2018, Nutrients.

[24]  J. Born,et al.  Insulin and Estrogen Independently and Differentially Reduce Macronutrient Intake in Healthy Men , 2018, The Journal of clinical endocrinology and metabolism.

[25]  E. McNay,et al.  Insulin modulates hippocampally-mediated spatial working memory via glucose transporter-4 , 2018, Behavioural Brain Research.

[26]  W. Hsu,et al.  Mechanism of intranasal drug delivery directly to the brain , 2018, Life sciences.

[27]  Terence J. Quinn.  Vascular cognitive impairment , 2018, Nature Reviews Disease Primers.

[28]  V. Lioutas,et al.  Intranasal insulin in Alzheimer’s dementia or mild cognitive impairment: a systematic review , 2018, Journal of Neurology.

[29]  Steven E. Arnold,et al.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums , 2018, Nature Reviews Neurology.

[30]  H. Schiöth,et al.  Intranasal insulin in Alzheimer’s disease: Food for thought , 2017, Neuropharmacology.

[31]  S. Amiel,et al.  Optimal prandial timing of bolus insulin in diabetes management: a review , 2017, Diabetic medicine : a journal of the British Diabetic Association.

[32]  H. Pijl,et al.  Effects of intranasal insulin application on the hypothalamic BOLD response to glucose ingestion , 2017, Scientific Reports.

[33]  H. Preissl,et al.  Hypothalamic insulin responsiveness is associated with pancreatic insulin secretion in humans , 2017, Physiology & Behavior.

[34]  M. Bondi,et al.  Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults , 2017, Front. Aging Neurosci..

[35]  I. Wilhelm,et al.  Intranasal insulin decreases circulating cortisol concentrations during early sleep in elderly humans , 2017, Neurobiology of Aging.

[36]  M. Karsdal,et al.  Metabolic Syndrome, Insulin Resistance, and Cognitive Dysfunction: Does Your Metabolic Profile Affect Your Brain? , 2017, Diabetes.

[37]  P. Klimek,et al.  Chronic Intranasal Insulin Does Not Affect Hepatic Lipids but Lowers Circulating BCAAs in Healthy Male Subjects , 2017, The Journal of clinical endocrinology and metabolism.

[38]  Bryan J. Neth,et al.  Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial , 2017, Journal of Alzheimer's disease : JAD.

[39]  R. Westendorp,et al.  Effect of intranasally administered insulin on cerebral blood flow and perfusion; a randomized experiment in young and older adults , 2017, Aging.

[40]  B. Sahakian,et al.  A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder. , 2017, Journal of affective disorders.

[41]  M. Hallschmid,et al.  Central Nervous Insulin Administration before Nocturnal Sleep Decreases Breakfast Intake in Healthy Young and Elderly Subjects , 2017, Diabetologie und Stoffwechsel.

[42]  J. Freiherr,et al.  Neural correlates of olfactory and visual memory performance in 3D-simulated mazes after intranasal insulin application , 2016, Neurobiology of Learning and Memory.

[43]  Hubert Preissl,et al.  Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans. , 2016, Physiological reviews.

[44]  Christina E. Wierenga,et al.  Higher Brain Perfusion May Not Support Memory Functions in Cognitively Normal Carriers of the ApoE ε4 Allele Compared to Non-Carriers , 2016, Front. Aging Neurosci..

[45]  Hubert Preissl,et al.  Impaired insulin action in the human brain: causes and metabolic consequences , 2015, Nature Reviews Endocrinology.

[46]  J. Born,et al.  Central Nervous Insulin Signaling in Sleep-Associated Memory Formation and Neuroendocrine Regulation , 2015, Neuropsychopharmacology.

[47]  M. Hallschmid,et al.  Intranasal Neuropeptide Administration To Target the Human Brain in Health and Disease. , 2015, Molecular pharmaceutics.

[48]  Klaus Scheffler,et al.  Selective Insulin Resistance in Homeostatic and Cognitive Control Brain Areas in Overweight and Obese Adults , 2015, Diabetes Care.

[49]  M. Roden,et al.  Effects of Intranasal Insulin on Hepatic Fat Accumulation and Energy Metabolism in Humans , 2015, Diabetes.

[50]  R. Veit,et al.  Central Insulin Administration Improves Whole-Body Insulin Sensitivity via Hypothalamus and Parasympathetic Outputs in Men , 2014, Diabetes.

[51]  Eugene J. Barrett,et al.  Insulin Regulates Brain Function, but How Does It Get There? , 2014, Diabetes.

[52]  M. Rosenbloom,et al.  A Single-Dose Pilot Trial of Intranasal Rapid-Acting Insulin in Apolipoprotein E4 Carriers with Mild–Moderate Alzheimer’s Disease , 2014, CNS Drugs.

[53]  G. Lewis,et al.  Intranasal Insulin Suppresses Endogenous Glucose Production in Humans Compared With Placebo in the Presence of Similar Venous Insulin Concentrations , 2014, Diabetes.

[54]  J. Born,et al.  Central Nervous Insulin Administration Does Not Potentiate the Acute Glucoregulatory Impact of Concurrent Mild Hyperinsulinemia , 2014, Diabetes.

[55]  Jing Fang,et al.  Intranasal Insulin Enhanced Resting-State Functional Connectivity of Hippocampal Regions in Type 2 Diabetes , 2014, Diabetes.

[56]  C. Kahn,et al.  Insulin Action in Brain Regulates Systemic Metabolism and Brain Function , 2014, Diabetes.

[57]  Michael W. Schwartz,et al.  Neurobiology of food intake in health and disease , 2014, Nature Reviews Neuroscience.

[58]  René Westerhausen,et al.  Intranasal insulin increases regional cerebral blood flow in the insular cortex in men independently of cortisol manipulation , 2014, Human brain mapping.

[59]  P. Novak,et al.  Enhancement of Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes , 2014, Diabetes Care.

[60]  H. Preissl,et al.  Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans. , 2014, The Journal of clinical endocrinology and metabolism.

[61]  J. Freiherr,et al.  Intranasal insulin reduces olfactory sensitivity in normosmic humans. , 2013, The Journal of clinical endocrinology and metabolism.

[62]  D. Goff,et al.  No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia , 2013, Schizophrenia Research.

[63]  D. Goff,et al.  No Effect of Adjunctive, Repeated-Dose Intranasal Insulin Treatment on Psychopathology and Cognition in Patients With Schizophrenia , 2013, Journal of clinical psychopharmacology.

[64]  S. Kennedy,et al.  A randomized, double‐blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder , 2012, Bipolar disorders.

[65]  Hubert Preissl,et al.  Intranasal Insulin Modulates Intrinsic Reward and Prefrontal Circuitry of the Human Brain in Lean Women , 2012, Neuroendocrinology.

[66]  Manfred Hallschmid,et al.  Intranasal Insulin Suppresses Food Intake via Enhancement of Brain Energy Levels in Humans , 2012, Diabetes.

[67]  R. Veit,et al.  Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions , 2012, Diabetologia.

[68]  Manfred Hallschmid,et al.  Postprandial Administration of Intranasal Insulin Intensifies Satiety and Reduces Intake of Palatable Snacks in Women , 2012, Diabetes.

[69]  C. Buettner,et al.  Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolism , 2011, Reviews in Endocrine and Metabolic Disorders.

[70]  H. Preissl,et al.  The Insulin-Mediated Modulation of Visually Evoked Magnetic Fields Is Reduced in Obese Subjects , 2011, PloS one.

[71]  D. Goff,et al.  No Effect of Single-Dose Intranasal Insulin Treatment on Verbal Memory and Sustained Attention in Patients With Schizophrenia , 2011, Journal of clinical psychopharmacology.

[72]  J. Born,et al.  Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory. , 2010, The Journal of clinical endocrinology and metabolism.

[73]  J. Born,et al.  Intranasal Insulin Enhances Postprandial Thermogenesis and Lowers Postprandial Serum Insulin Levels in Healthy Men , 2010, Diabetes.

[74]  R. Rizza.  Pathogenesis of Fasting and Postprandial Hyperglycemia in Type 2 Diabetes: Implications for Therapy , 2010, Diabetes.

[75]  Hubert Preissl,et al.  Insulin modulates food-related activity in the central nervous system. , 2010, The Journal of clinical endocrinology and metabolism.

[76]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[77]  Suzanne Craft,et al.  The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. , 2009, Archives of neurology.

[78]  L. Schwabe,et al.  Intranasal insulin attenuates the hypothalamic–pituitary–adrenal axis response to psychosocial stress , 2008, Psychoneuroendocrinology.

[79]  L. Wilkins.  Intranasal insulin improves cognition and modulates β-amyloid in early AD , 2008, Neurology.

[80]  J. Born,et al.  Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. , 2008, The Journal of clinical endocrinology and metabolism.

[81]  P. Mehta,et al.  Intranasal insulin improves cognition and modulates β-amyloid in early AD , 2008, Neurology.

[82]  J. Born,et al.  Obese men respond to cognitive but not to catabolic brain insulin signaling , 2008, International Journal of Obesity.

[83]  J. Born,et al.  Intranasal Insulin to Improve Memory Function in Humans , 2007, Neuroendocrinology.

[84]  Gregory G. Brown,et al.  Measurement of cerebral perfusion with arterial spin labeling: Part 1. Methods , 2007, Journal of the International Neuropsychological Society.

[85]  J. Born,et al.  Low cerebrospinal fluid insulin levels in obese humans , 2006, Diabetologia.

[86]  G. Schellenberg,et al.  Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype , 2006, Neurobiology of Aging.

[87]  A. Artola,et al.  Insulin modulates hippocampal activity‐dependent synaptic plasticity in a N‐methyl‐d‐aspartate receptor and phosphatidyl‐inositol‐3‐kinase‐dependent manner , 2005, Journal of neurochemistry.

[88]  Jan Born,et al.  Intranasal insulin reduces body fat in men but not in women. , 2004, Diabetes.

[89]  Jan Born,et al.  Intranasal insulin improves memory in humans , 2004, Psychoneuroendocrinology.

[90]  M. Knip,et al.  Intranasally administered insulin intended for prevention of type 1 diabetes—a safety study in healthy adults , 2003, Diabetes/metabolism research and reviews.

[91]  D. O’Malley,et al.  Insulin inhibits rat hippocampal neurones via activation of ATP-sensitive K+ and large conductance Ca2+-activated K+ channels , 2003, Neuropharmacology.

[92]  T. Pagano,et al.  Insulin receptors and insulin action in the brain: review and clinical implications , 2000, Neuroscience & Biobehavioral Reviews.

[93]  C. Sartori,et al.  Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. , 1997, Circulation.

[94]  C. Ackerley,et al.  Recruitment of functional GABAA receptors to postsynaptic domains by insulin , 1997, Nature.

[95]  S. Davis,et al.  Intranasal Insulin , 1992, Clinical pharmacokinetics.

[96]  Mustafa Saad,et al.  Implications for Therapy , 2016 .

[97]  G. Zaharchuk,et al.  Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. , 2015, Magnetic resonance in medicine.

[98]  Emily H. Trittschuh,et al.  Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. , 2015, Journal of Alzheimer's disease : JAD.

[99]  J. Freiherr,et al.  Central insulin administration improves odor-cued reactivation of spatial memory in young men. , 2015, The Journal of clinical endocrinology and metabolism.

[100]  Suzanne Craft,et al.  Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[101]  T. Montine,et al.  Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial , 2011 .

[102]  D. Bennett,et al.  AHA / ASA Scientific Statement Vascular Contributions to Cognitive Impairment and Dementia , 2011 .

[103]  G. Schellenberg,et al.  Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. , 2008, Journal of Alzheimer's disease : JAD.

[104]  J. Wands,et al.  Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? , 2005, Journal of Alzheimer's disease : JAD.

[105]  K. Jellinger,et al.  Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease , 1998, Journal of Neural Transmission.

[106]  Hubert Preissl,et al.  Frontiers in Systems Neuroscience Systems Neuroscience , 2022 .